Back to Sites Harare Family Care CRS Site Number 31890 Address Cnr Josiah Tongogara/Mazowe Street Parirenyatwa Annex Harare, Zimbabwe IMPAACT Members at this Site David Mburuzabudu CAB Member Audry Tasaranarwo CAB Member Reginald Maonedzo CAB Representative Gift Chareka Co-Investigator Zvenyika Alfred R. Gomo Co-Investigator Francis Jaji Co-Investigator Mavis Kahwemba Co-Investigator Suzen Maonera Co-Investigator Hilda Mujuru Co-Investigator Richard Musana Co-Investigator Mercy Mutambanengwe Co-Investigator Rachel Mahachi CRS Coordinator Sukunena Maturure CRS Coordinator Mutsawashe Bwakura-Dangarembizi CRS Leader James Hakim CRS Leader Zvavahera Chirenje CTU Principal Investigator Bola Adedeji DAIDS PO Rufaro Katsande Data Manager Tichaona Vhembo Investigator Marshall Munjoma Laboratory Manager/Supervisor Bangani Kusakara Medical Officer Tapiwa Mbengeranwa Medical Officer Tsungai Mhembere Pharmacist of Record Studies at this Site P1060: NNRTI-Based vs. PI-Based ART in Infants Exposed/Not Exposed to NVP for PMTCT DAIDS Number 10166 Research Area Treatment Study Status Concluded P1070: EFV in HIV-infected and HIV/TB Co-infected Subjects DAIDS Number 10633 Research Area Treatment Study Status Concluded P1072: Safety and Immunogenicity of a Live, Attenuated, Rotavirus Vaccine (RotaTeqâ„¢) in HIV-1 Infected and Uninfected Children Born to HIV-1 Infected Mothers DAIDS Number 10638 Research Area Complications & Comorbidities Study Status Concluded P1073: Study of Immune Reconstitution Inflammatory Syndrome (IRIS) for International Sites Initiating Highly Active Antiretroviral Therapy (HAART) in Infants and Children <72 Months of Age DAIDS Number 10655 Research Area Other Study Status Concluded P1078: TB APPRISE: TB Ante vs. Postpartum Prevention with INH in HIV Seropositive mothers and their Exposed infants DAIDS Number 10732 Research Area Tuberculosis P1084s: Maternal Infant TDF Toxicity Safety DAIDS Number 10790 Research Area Complications & Comorbidities Study Status Closed to Follow Up P1092: Phase IV Evaluation of the Steady State Pharmacokinetics of Zidovudine, Lamivudine, and Lopinavir/Ritonavir in Severely Malnourished HIV-1 Infected Children DAIDS Number 11689 Research Area Treatment Study Status Participants Off Study and Primary Analysis Completed P1093: PK, Safety, Tolerability and Antiviral Activity of Dolutegravir DAIDS Number 11773 Research Area Treatment Study Status Closed to Accrual 1077BF: PROMISE 1077BF DAIDS Number 10777 Research Area Prevention Study Status Participants Off Study and Primary Analysis Completed P1104s: Longitudinal Developmental and Neuropsychological Assessments of HIV-Infected Participants of P1060 and HIV-Uninfected Controls DAIDS Number 11878 Research Area Complications & Comorbidities Study Status Participants Off Study and Primary Analysis Completed Pagination Current page 1 Page 2 Next page Next
P1060: NNRTI-Based vs. PI-Based ART in Infants Exposed/Not Exposed to NVP for PMTCT DAIDS Number 10166 Research Area Treatment Study Status Concluded
P1070: EFV in HIV-infected and HIV/TB Co-infected Subjects DAIDS Number 10633 Research Area Treatment Study Status Concluded
P1072: Safety and Immunogenicity of a Live, Attenuated, Rotavirus Vaccine (RotaTeqâ„¢) in HIV-1 Infected and Uninfected Children Born to HIV-1 Infected Mothers DAIDS Number 10638 Research Area Complications & Comorbidities Study Status Concluded
P1073: Study of Immune Reconstitution Inflammatory Syndrome (IRIS) for International Sites Initiating Highly Active Antiretroviral Therapy (HAART) in Infants and Children <72 Months of Age DAIDS Number 10655 Research Area Other Study Status Concluded
P1078: TB APPRISE: TB Ante vs. Postpartum Prevention with INH in HIV Seropositive mothers and their Exposed infants DAIDS Number 10732 Research Area Tuberculosis
P1084s: Maternal Infant TDF Toxicity Safety DAIDS Number 10790 Research Area Complications & Comorbidities Study Status Closed to Follow Up
P1092: Phase IV Evaluation of the Steady State Pharmacokinetics of Zidovudine, Lamivudine, and Lopinavir/Ritonavir in Severely Malnourished HIV-1 Infected Children DAIDS Number 11689 Research Area Treatment Study Status Participants Off Study and Primary Analysis Completed
P1093: PK, Safety, Tolerability and Antiviral Activity of Dolutegravir DAIDS Number 11773 Research Area Treatment Study Status Closed to Accrual
1077BF: PROMISE 1077BF DAIDS Number 10777 Research Area Prevention Study Status Participants Off Study and Primary Analysis Completed
P1104s: Longitudinal Developmental and Neuropsychological Assessments of HIV-Infected Participants of P1060 and HIV-Uninfected Controls DAIDS Number 11878 Research Area Complications & Comorbidities Study Status Participants Off Study and Primary Analysis Completed